Royal Bank of Canada’s Aerie Pharmaceuticals AERI Stock Holding History

Royal Bank of Canada’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40,500	Closed	-$1.2M	–	7302
2019 Q2	$1.2M	Buy	+40,500	New	+$1.56M	﹤0.01%	3164

Royal Bank of Canada's AERI Position: Q4 2022 in Review

Royal Bank of Canada sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 6,923 shares — an estimated $105K sold.

Royal Bank of Canada first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $4.07M in Q2 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Royal Bank of Canada reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Royal Bank of Canada sold 6,923 Aerie Pharmaceuticals shares in Q4 2022, an estimated $105K.
Royal Bank of Canada first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
Royal Bank of Canada's Aerie Pharmaceuticals position peaked at $4.07M in Q2 2017.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.